Guggenheim Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.87M Buy
122,930
+5,038
+4% +$331K 0.05% 342
2026
Q1
$8.39M Sell
117,892
-20,149
-15% -$1.59M 0.07% 302
2025
Q4
$11.3M Buy
138,041
+3,807
+3% +$297K 0.08% 254
2025
Q3
$10.1M Buy
134,234
+2,249
+2% +$168K 0.07% 269
2025
Q2
$9.78M Buy
131,985
+24,087
+22% +$1.68M 0.08% 253
2025
Q1
$8.71M Sell
107,898
-24,601
-19% -$2.11M 0.08% 276
2024
Q4
$10.4M Buy
132,499
+5,926
+5% +$504K 0.08% 242
2024
Q3
$11.9M Sell
126,573
-2,507
-2% -$210K 0.08% 253
2024
Q2
$10.1M Sell
129,080
-2,143
-2% -$175K 0.07% 303
2024
Q1
$11.9M Sell
131,223
-1,271
-1% -$106K 0.08% 263
2023
Q4
$10.2M Buy
132,494
+16,113
+14% +$1.13M 0.08% 304
2023
Q3
$7.92M Buy
116,381
+18,209
+19% +$1.32M 0.07% 338
2023
Q2
$7.98M Buy
98,172
+88,101
+875% +$7.03M 0.06% 368
2023
Q1
$826K Buy
+10,071
New +$719K 0.01% 1274

Other funds holding GEHC

Guggenheim Capital's GEHC Position: Q2 2026 in Review

Guggenheim Capital increased its GE HealthCare (GEHC) stake by 4.3% in Q2 2026, buying an estimated $331K and bringing the position to 122,930 shares worth $7.87M. The position accounts for 0.05% of the portfolio, ranked #342.

Guggenheim Capital first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $11.9M in Q1 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Guggenheim Capital held 122,930 shares of GE HealthCare worth $7.87M as of Q2 2026.
  • Guggenheim Capital bought 5,038 GE HealthCare shares in Q2 2026, an estimated $331K.
  • GE HealthCare made up 0.05% of Guggenheim Capital's portfolio in Q2 2026, its #342 holding.
  • Guggenheim Capital first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Guggenheim Capital's GE HealthCare position peaked at $11.9M in Q1 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.